These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

887 related articles for article (PubMed ID: 27696531)

  • 1. Effect of narrow band ultraviolet B phototherapy as monotherapy or combination therapy for vitiligo: a meta-analysis.
    Li R; Qiao M; Wang X; Zhao X; Sun Q
    Photodermatol Photoimmunol Photomed; 2017 Jan; 33(1):22-31. PubMed ID: 27696531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An open randomized study to compare narrow band UVB, topical pimecrolimus and topical tacrolimus in the treatment of vitiligo.
    Stinco G; Piccirillo F; Forcione M; Valent F; Patrone P
    Eur J Dermatol; 2009; 19(6):588-93. PubMed ID: 19651562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of narrow band UVB and topical calcipotriol for the treatment of vitiligo.
    Goktas EO; Aydin F; Senturk N; Canturk MT; Turanli AY
    J Eur Acad Dermatol Venereol; 2006 May; 20(5):553-7. PubMed ID: 16684283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacalcitol and narrow-band phototherapy in patients with vitiligo.
    Leone G; Pacifico A; Iacovelli P; Paro Vidolin A; Picardo M
    Clin Exp Dermatol; 2006 Mar; 31(2):200-5. PubMed ID: 16487090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Narrow-band UVB311 nm vs. broad-band UVB therapy in combination with topical calcipotriol vs. placebo in vitiligo.
    Hartmann A; Lurz C; Hamm H; Bröcker EB; Hofmann UB
    Int J Dermatol; 2005 Sep; 44(9):736-42. PubMed ID: 16135141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical calcipotriene and narrowband ultraviolet B in the treatment of vitiligo.
    Kullavanijaya P; Lim HW
    Photodermatol Photoimmunol Photomed; 2004 Oct; 20(5):248-51. PubMed ID: 15379875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study.
    Middelkamp-Hup MA; Bos JD; Rius-Diaz F; Gonzalez S; Westerhof W
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):942-50. PubMed ID: 17659004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does topical tacrolimus ointment enhance the efficacy of narrowband ultraviolet B therapy in vitiligo? A left-right comparison study.
    Majid I
    Photodermatol Photoimmunol Photomed; 2010 Oct; 26(5):230-4. PubMed ID: 20831696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: a preliminary randomized controlled study.
    Asawanonda P; Klahan SO
    Photomed Laser Surg; 2010 Oct; 28(5):679-84. PubMed ID: 20961233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of fractional carbon dioxide laser combined with narrow-band ultraviolet B phototherapy for non-segmental vitiligo: a systematic review and meta-analysis.
    Kim WI; Kim S; Lee SH; Cho MK
    Lasers Med Sci; 2021 Feb; 36(1):165-173. PubMed ID: 32572662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of 110 patients.
    Fai D; Cassano N; Vena GA
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):916-20. PubMed ID: 17659000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of narrow-band ultraviolet B on the serum of 25-hydroxyvitamin D in vitiligo patients.
    Ibrahim H; El Taieb M; El Gamel Z; El Saied AR
    J Cosmet Dermatol; 2018 Oct; 17(5):911-916. PubMed ID: 29524288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical treatment and combination approaches for vitiligo: new insights, new developments.
    Hossani-Madani AR; Halder RM
    G Ital Dermatol Venereol; 2010 Feb; 145(1):57-78. PubMed ID: 20197746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo.
    Arca E; Taştan HB; Erbil AH; Sezer E; Koç E; Kurumlu Z
    J Dermatol; 2006 May; 33(5):338-43. PubMed ID: 16700666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of efficacy and safety profile of topical calcipotriol ointment in combination with NB-UVB vs. NB-UVB alone in the treatment of vitiligo: a 24-week prospective right-left comparative clinical trial.
    Khullar G; Kanwar AJ; Singh S; Parsad D
    J Eur Acad Dermatol Venereol; 2015 May; 29(5):925-32. PubMed ID: 25220387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of efficacy of narrow band UVB therapies with UVB alone, in combination with calcipotriol, and with betamethasone and calcipotriol in vitiligo.
    Akdeniz N; Yavuz IH; Gunes Bilgili S; Ozaydın Yavuz G; Calka O
    J Dermatolog Treat; 2014 Jun; 25(3):196-9. PubMed ID: 23441902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of NB-UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor-to-recipient ratios.
    Tawfik YM; Abd Elazim NE; Abdel-Motaleb AA; Mohammed RAA; Tohamy AMA
    J Cosmet Dermatol; 2019 Apr; 18(2):638-646. PubMed ID: 30280485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment outcome and persistence of repigmentation from narrow-band ultraviolet B phototherapy in vitiligo.
    Silpa-Archa N; Weerasubpong P; Junsuwan N; Yothachai P; Supapueng O; Wongpraparut C
    J Dermatolog Treat; 2019 Nov; 30(7):691-696. PubMed ID: 30474443
    [No Abstract]   [Full Text] [Related]  

  • 19. Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial.
    Dell'Anna ML; Mastrofrancesco A; Sala R; Venturini M; Ottaviani M; Vidolin AP; Leone G; Calzavara PG; Westerhof W; Picardo M
    Clin Exp Dermatol; 2007 Nov; 32(6):631-6. PubMed ID: 17953631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined therapy for resistant vitiligo lesions: NB-UVB, microneedling, and topical latanoprost, showed no enhanced efficacy compared to topical latanoprost and NB-UVB.
    Stanimirovic A; Kovacevic M; Korobko I; Šitum M; Lotti T
    Dermatol Ther; 2016 Sep; 29(5):312-316. PubMed ID: 27356486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.